Appropriate surveillance includes:

Periodic neurodevelopmental and behavioral evaluations to assist in the management of cognitive and behavioral problems;

Periodic reevaluations by a clinical geneticist to provide new recommendations and information regarding MBD5 haploinsufficiency.
